A multi-center, randomized, open label, controlled study to compare the Sustained Virological Response during treatment with Neoral or tacrolimus in maintenance liver transplant recipients treated with pegylated interferon and ribavirin for recurrent Hepatitis C
Phase of Trial: Phase IV
Latest Information Update: 02 May 2016
At a glance
- Drugs Ciclosporin (Primary) ; Peginterferon; Ribavirin; Tacrolimus
- Indications Hepatitis C; Liver transplant rejection
- Focus Therapeutic Use
- Acronyms SUSTAIN
- Sponsors Novartis; Novartis Pharmaceuticals
- 01 May 2016 This study is suspended in Italy as per European Clinical Trials Database record.
- 04 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.